Results 1 to 10 of about 1,960,750 (298)

Global differences and risk factors influencing drug hypersensitivity quality of life: A multicenter, multiethnic study of drug allergy across 3 continents. [PDF]

J Allergy Clin Immunol Glob
Copaescu AM, Mak HWF, Vogrin S, Holmes NE, Trubiano JA, Li PH.   +5 more
europepmc   +1 more source

Maculopapular rash with multiple drug hypersensitivity to cotrimoxazole, amikacin, piperacillin/tazobactam, and meropenem in a patient with hairy cell leukemia. [PDF]

Allergol Select
Townsend K, Leck C, Billahalli T, Barachina E, Watts TJ.   +4 more
europepmc   +1 more source

Healthcare Providers' knowledge, attitudes and practice in relation to drug hypersensitivity reactions at King Abdulaziz Medical City in Riyadh. [PDF]

Saudi Pharm J
Alrashed M, Alanazi AA, Bin Saleh K, Alanazi F, Alanazi AS, Mashraqi S, Mahdali M, Alshammari A, Alnuhait MA, Alzahrani M, Alqahtani T.   +10 more
europepmc   +1 more source

Systemic and skin-limited delayed-type drug hypersensitivity reactions associate with distinct resident and recruited T cell subsets. [PDF]

J Clin Invest
Shah PN, Romar GA, Manukyan A, Ko WC, Hsieh PC, Velasquez GA, Schunkert EM, Fu X, Guleria I, Bronson RT, Wei K, Waldman AH, Vleugels FR, Liang MG, Giobbie-Hurder A, Mostaghimi A, Schmidt BA, Barrera V, Foreman RK, Garber M, Divito SJ.   +20 more
europepmc   +1 more source

Antituberculosis-Drugs Induced DRESS: A Multidrug Hypersensitivity or Drug Hypersensitivity Relapse? A Case Report. [PDF]

Hosp Pharm
Mansour K, Chadli Z, Ben Fadhel N, Ben Fredj N, Ben Romdhane H, Chaabane A, Toumi A, Aouam K.   +7 more
europepmc   +1 more source

Toxic epidermal necrolysis-like linear IgA bullous dermatosis as a manifestation of multiple drug hypersensitivity in the setting of drug reaction with eosinophilia and systemic symptoms. [PDF]

JAAD Case Rep
Stratman S, Zhou L, Kim RH, Phelps RG, Glickman J, Mikhaylov D, Wu J, El-Kashlan N, Rivera-Oyola R, Adalsteinsson JA, Levoska MA, Gulati N.   +11 more
europepmc   +1 more source

Drug Hypersensitivity Reactions

Emergency Medicine Clinics of North America, 2022
Drug hypersensitivity reactions are a diverse group of reactions mediated by the immune system after exposure to a drug. The Gell and Coombs classification divides immunologic DHRs into 4 major pathophysiologic categories based on immunologic mechanism. Anaphylaxis is a Type I hypersensitivity reaction that requires immediate recognition and treatment.
Richard Wilkerson
exaly   +4 more sources

Telemedicine in Drug Hypersensitivity

Immunology and Allergy Clinics of North America, 2022
This review focuses on the current applications of telemedicine for drug hypersensitivity reactions. Telemedicine holds promise as a tool to risk-stratify patients with drug hypersensitivity, for both evaluation of penicillin allergies and severe cutaneous adverse reactions.
Deva, Wells, Katherine L, DeNiro, Allison, Ramsey   +2 more
openaire   +3 more sources

Pathophysiology of drug hypersensitivity

British Journal of Clinical Pharmacology, 2023
Drug hypersensitivity reactions (DHRs) are type B adverse drug reactions (ADRs) traditionally defined as unpredictable, dose independent and not related to the drug pharmacology. DHRs, also called drug allergy if the immune system involvement is confirmed, represent around one‐sixth of all ADRs and can cause major clinical problems due to their vague ...
Abdelbaset A. Elzagallaai, Michael J. Rieder   +1 more
openaire   +2 more sources

Hypersensitivity to antiretroviral drugs [PDF]

European Annals of Allergy and Clinical Immunology, 2018
Background. Antiretroviral therapy (ART) may be responsible for hypersensitivity reactions varying in severity, clinical manifestations and frequency. Case report. We report the case of a 47-year-old woman with HIV infection who developed a delayed mucocutaneous reaction after treatment with ART.
M J, Sousa, S, Cadinha, M, Mota, T, Teixeira, D, Malheiro, J P, Moreira da Silva   +5 more
openaire   +2 more sources